- Report
- February 2024
- 79 Pages
Global
From €8926EUR$9,995USD£7,869GBP
- Report
- August 2022
- 95 Pages
Global
From €3572EUR$4,000USD£3,149GBP
- Newsletter
- November 2025
- 2 Pages
Global
From €117EUR$131USD£103GBP
- Report
- August 2025
- 81 Pages
From €3081EUR$3,450USD£2,716GBP
- Report
- March 2025
- 201 Pages
China
From €3572EUR$4,000USD£3,149GBP
- Report
- August 2024
- 207 Pages
China
From €3572EUR$4,000USD£3,149GBP
- Report
- August 2024
- 238 Pages
China
From €3572EUR$4,000USD£3,149GBP
- Report
- June 2024
- 200 Pages
Global
From €5680EUR$6,360USD£5,007GBP
€7100EUR$7,950USD£6,259GBP
- Report
- February 2024
- 25 Pages
Global
€15316EUR$17,150USD£13,503GBP
- Report
- November 2023
- 162 Pages
Global
From €2233EUR$2,500USD£1,968GBP
- Report
- October 2023
- 85 Pages
United States
From €4331EUR$4,850USD£3,819GBP
- Report
- August 2023
- 180 Pages
Global
From €3349EUR$3,750USD£2,952GBP
- Report
- July 2023
- 32 Pages
Global
€10940EUR$12,250USD£9,645GBP
- Report
- July 2023
- 200 Pages
Global
From €4019EUR$4,500USD£3,543GBP
- Report
- July 2023
- 218 Pages
Global
From €4019EUR$4,500USD£3,543GBP
- Report
- July 2023
- 179 Pages
Global
From €4019EUR$4,500USD£3,543GBP
- Report
- June 2023
- 22 Pages
Global
€10940EUR$12,250USD£9,645GBP
- Report
- April 2023
- 110 Pages
Global
From €4242EUR$4,750USD£3,740GBP
- Report
- February 2023
- 27 Pages
Global
€10940EUR$12,250USD£9,645GBP
- Report
- January 2023
- 28 Pages
Global
€10940EUR$12,250USD£9,645GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more